Abstract
Correction: Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have